Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model. (Q51769139)

11 April 2018

title

Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model. (English)

1 reference

11 April 2018

1 reference

Deanna S Deveson Lucas

1

1 reference

11 April 2018

Paul A Cullen

2

1 reference

11 April 2018

Miranda Lo

3

1 reference

11 April 2018

Amporn Srikram

4

1 reference

11 April 2018

Rasana W Sermswan

5

1 reference

11 April 2018

Ben Adler

6

1 reference

11 April 2018

language of work or name

English

0 references

publication date

9 March 2011

1 reference

11 April 2018

published in

Vaccine

1 reference

11 April 2018

volume

29

1 reference

11 April 2018

issue

18

1 reference

11 April 2018

page(s)

3413-3418

1 reference

11 April 2018

Opsonic monoclonal antibodies against lipopolysaccharide antigens of Leptospira interrogans serovar hardjo

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Comparison of three different leptospiral vaccines for induction of a type 1 immune response to Leptospira borgpetersenii serovar Hardjo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Surfaceome of Leptospira spp.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Leptospiral proteins recognized during the humoral immune response to leptospirosis in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Leptospira and leptospirosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

LipL32 is an extracellular matrix-interacting protein of Leptospira spp. and Pseudoalteromonas tunicata

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

In LipL32, the major leptospiral lipoprotein, the C terminus is the primary immunogenic domain and mediates interaction with collagen IV and plasma fibronectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Calcium Binds to LipL32, a Lipoprotein from Pathogenic Leptospira, and Modulates Fibronectin Binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Major surface protein LipL32 is not required for either acute or chronic infection with Leptospira interrogans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Epitope mapping of pathogenic Leptospira LipL32.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Osmolarity, a key environmental signal controlling expression of leptospiral proteins LigA and LigB and the extracellular release of LigA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Leptospiral immunoglobulin-like proteins elicit protective immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Vaccine adjuvants: current state and future trends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Genome-wide transposon mutagenesis in pathogenic Leptospira species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Hamster model of leptospirosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Cross-protective immunity against leptospirosis elicited by a live, attenuated lipopolysaccharide mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

10.1016/J.VACCINE.2011.02.084

7 January 2021

Identifiers

DOI

1 reference

11 April 2018

PubMed ID

21396409

1 reference

11 April 2018